今日观察！A Wave of "Kete Valuation" Sweeps Through the Market: 50 Stocks Poised for Strong Growth

A Wave of "Kete Valuation" Sweeps Through the Market: 50 Stocks Poised for Strong Growth

Shanghai, China - June 17, 2024 - A recent surge in investor sentiment towards growth stocks, particularly in the healthcare and technology sectors, has been dubbed the "Kete Valuation" phenomenon, named after the Chinese pharmaceutical company C-Bridge (6160.HK). This trend is reminiscent of the "CATL Valuation" rally that occurred in 2021, driven by the strong performance of Contemporary Amperex Technology Co., Ltd. (300015.SZ).

The "Kete Valuation" is characterized by a sharp increase in the share prices of companies with promising growth prospects, often defying broader market trends. This is evident in the recent performance of 50 stocks identified by analysts as having significant growth potential. These stocks, spanning various industries including healthcare, technology, and consumer goods, have exhibited remarkable resilience amidst recent market volatility.

Factors Driving the "Kete Valuation"

Several factors are contributing to the "Kete Valuation" trend. Firstly, investors are increasingly seeking out companies that can deliver sustainable growth, particularly in the face of global economic uncertainties. Secondly, the easing of monetary policy in major economies is providing a supportive backdrop for riskier assets like growth stocks. Additionally, advancements in technology and innovation are creating new opportunities for companies in various sectors, fueling investor optimism.

Key Beneficiaries of the "Kete Valuation"

Among the 50 stocks identified as potential beneficiaries of the "Kete Valuation," C-Bridge (6160.HK) stands out as a frontrunner. The company's innovative cancer therapies and strong pipeline of new drugs have attracted significant investor interest. Other notable stocks include:

• Ascletis Pharma (1672.HK): A clinical-stage biopharmaceutical company developing novel therapies for cancer and viral diseases.

• Aier Eye Hospital Group (300015.SZ): A leading provider of comprehensive eye care services in China.

• Xiaomi Corporation (1810.HK): A global technology company known for its smartphones, smart home devices, and internet services.

Investment Implications

The "Kete Valuation" presents an opportunity for investors to capitalize on the growth potential of select companies. However, careful due diligence is crucial, as not all growth stocks are created equal. Investors should thoroughly evaluate a company's financial health, competitive landscape, and long-term growth prospects before making investment decisions.

The "Kete Valuation" highlights the evolving dynamics of the Chinese stock market, where investors are increasingly discerning and seeking out companies with genuine growth potential. This trend is likely to continue as China's economy transitions towards a more innovation-driven and knowledge-based model.

美股三大股指期货齐跌 避险情绪升温

纽约讯 6月14日，美国股指期货周二全线走低，三大股指期货均有所下跌。截至纽约商品交易所东部时间下午5点15分，道指期货下跌65点，至33128点，跌幅0.20%；标普500指数期货下跌45点，至4172.50点，跌幅0.11%；纳斯达克综合指数期货下跌24点，至13122点，跌幅0.18%。

投资者转向避险资产，原因是法国政治局势的不确定性加剧，以及对美联储未来加息步伐的担忧。法国总统埃马纽埃尔·马克龙（Emmanuel Macron）所在的政党在欧洲议会选举中惨败，引发市场担忧其在即将举行的立法选举中可能失去多数席位。这可能导致法国政府实施更宽松的财政政策，并加剧欧元区整体的债务风险。

此外，市场也担心美联储可能比预期更早结束加息周期。美国5月份非农就业数据强劲，令投资者对美联储今年下半年降息的预期有所降温。一些分析师认为，美联储可能会在2025年开始降息，但也有分析师认为，美联储可能会维持利率不变，直到通胀得到更有效的控制。

具体来看，欧洲股市普遍下跌。德国DAX指数下跌1.12%，英国富时100指数下跌0.10%，法国CAC 40指数下跌2.15%，欧洲斯托克50指数下跌1.44%。

在避险资产方面，美国国债价格上涨，收益率下降。10年期美国国债收益率下跌5个基点，至3.15%。美元兑主要货币汇率也普遍上涨。

个股方面，金山云盘前涨超2%，此前公司发布第九代云服务器SE9，光大证券指出，AI将成为推动公有云业务增长的重要引擎，预计24年毛利率有望提升至17%。

总体而言，今天的市场情绪较为谨慎。投资者正在观望法国政治局势的发展，并评估美联储未来加息的可能性。在避险情绪升温的情况下，美国国债和美元等避险资产受到青睐。